Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
50.33
-0.53 (-1.04%)
At close: Nov 6, 2026, 4:00 PM EST
50.40
+0.07 (0.14%)
After-hours: Nov 6, 2026, 7:30 PM EST
Qiagen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,116 | 2,090 | 1,978 | 1,965 | 2,142 | 2,252 | |
Revenue Growth | 2.17% | 5.65% | 0.66% | -8.23% | -4.89% | 20.39% |
Cost of Revenue | 699.18 | 703.03 | 657.22 | 667.43 | 696.08 | 733.72 |
Gross Profit | 1,416 | 1,387 | 1,321 | 1,298 | 1,445 | 1,518 |
Selling, General & Admin | 589.16 | 583.67 | 564.36 | 579.17 | 603.95 | 584.47 |
Research & Development | 199.87 | 187.52 | 193.49 | 198.51 | 189.86 | 189.96 |
Amortization of Goodwill & Intangibles | 62.44 | 63.24 | 68.14 | 74.96 | 75.01 | 85.66 |
Operating Expenses | 851.47 | 834.42 | 825.99 | 852.64 | 868.82 | 860.09 |
Operating Income | 565 | 552.54 | 495 | 445.25 | 576.62 | 657.85 |
Interest Expense | -41.7 | -33.26 | -43.84 | -53.41 | -58.36 | -54.48 |
Interest & Investment Income | 50.68 | 64.32 | 68.02 | 78.99 | 32.76 | 9.56 |
Earnings From Equity Investments | 7 | 4.4 | 5.72 | 4.16 | 3.76 | - |
Currency Exchange Gain (Loss) | -6.1 | -8.4 | -4.5 | -5.8 | 2.7 | -9 |
Other Non Operating Income (Expenses) | 0.29 | -0.15 | 0.69 | -4.07 | 0.28 | 17.37 |
EBT Excluding Unusual Items | 575.17 | 579.46 | 521.09 | 465.12 | 557.76 | 621.3 |
Merger & Restructuring Charges | -93.87 | -63.46 | -397.29 | -35.31 | -5 | - |
Gain (Loss) on Sale of Investments | 0.5 | -2.5 | -2.65 | - | - | 32.3 |
Asset Writedown | - | - | - | - | -12.97 | - |
Legal Settlements | 4.7 | 4.7 | - | - | - | - |
Other Unusual Items | -27.09 | -27.94 | - | - | -27.19 | -27.76 |
Pretax Income | 459.42 | 490.27 | 121.15 | 429.81 | 512.6 | 625.83 |
Income Tax Expense | 74.48 | 65.39 | 37.56 | 88.51 | 89.39 | 113.23 |
Earnings From Continuing Operations | 384.93 | 424.88 | 83.59 | 341.3 | 423.21 | 512.6 |
Net Income | 384.93 | 424.88 | 83.59 | 341.3 | 423.21 | 512.6 |
Net Income to Common | 384.93 | 424.88 | 83.59 | 341.3 | 423.21 | 512.6 |
Net Income Growth | -5.04% | 408.28% | -75.51% | -19.35% | -17.44% | 42.71% |
Shares Outstanding (Basic) | 206 | 206 | 206 | 204 | 204 | 204 |
Shares Outstanding (Diluted) | 208 | 208 | 208 | 207 | 206 | 208 |
Shares Change | -0.54% | 0.18% | 0.45% | 0.21% | -0.82% | -0.93% |
EPS (Basic) | 1.86 | 2.06 | 0.41 | 1.67 | 2.08 | 2.51 |
EPS (Diluted) | 1.85 | 2.04 | 0.40 | 1.65 | 2.05 | 2.47 |
EPS Growth | -4.65% | 409.76% | -75.75% | -19.56% | -16.74% | 44.44% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 435.77 | 453.28 | 506.38 | 309.75 | 586.04 | 449.1 |
Free Cash Flow Per Share | 2.09 | 2.18 | 2.44 | 1.50 | 2.84 | 2.16 |
Dividend Per Share | 0.350 | 0.263 | - | - | - | - |
Dividend Growth | 32.98% | - | - | - | - | - |
Gross Margin | 66.95% | 66.36% | 66.78% | 66.04% | 67.50% | 67.41% |
Operating Margin | 26.71% | 26.44% | 25.02% | 22.66% | 26.93% | 29.22% |
Profit Margin | 18.20% | 20.33% | 4.23% | 17.37% | 19.76% | 22.77% |
Free Cash Flow Margin | 20.60% | 21.69% | 25.60% | 15.76% | 27.37% | 19.95% |
EBITDA | 751.24 | 728.29 | 685.27 | 638.88 | 774.22 | 863.58 |
EBITDA Margin | 35.51% | 34.85% | 34.64% | 32.51% | 36.15% | 38.35% |
D&A For EBITDA | 186.24 | 175.75 | 190.27 | 193.64 | 197.6 | 205.73 |
EBIT | 565 | 552.54 | 495 | 445.25 | 576.62 | 657.85 |
EBIT Margin | 26.71% | 26.44% | 25.02% | 22.66% | 26.93% | 29.22% |
Effective Tax Rate | 16.21% | 13.34% | 31.00% | 20.59% | 17.44% | 18.09% |
Advertising Expenses | - | 8.7 | 9.6 | 11.5 | 15.8 | 13.5 |